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Introduction: Intraoperative gold standards in the management of 
lung cancer include performing anatomical resection and mediastinal 
lymphadenectomy). Our aim was to measure improvement in quality 
of surgery by reauditing anatomical resection and lymph node exci-
sion in patients undergoing lung cancer surgery as per gold standards.
Methods: A complete audit cycle was performed—an initial ret-
rospective analysis of 100 consecutive patients with primary lung 
cancer operated on by a single surgeon (July 2009–October 2010), 
followed by a prospective reaudit of 102 patients (November 
2010–October 2011). Clinical and pathological data were collected 
from clinical notes, surgical database, and histopathology reports. 
Univariate and multivariate analyses were performed to identify fur-
ther areas of potential improvement.
Results: The number of nonanatomical resections dropped from 12% 
to 6% (p = not significant). The rate of performing excision of at least 
1, 2, and 3 mediastinal (N
2
) lymph node stations improved from 86% to 
91%, 63% to 77%, and 40% to 63%, respectively (p = 0.003). On mul-
tivariate analysis, failure to perform anatomical resection was related 
to use of video assisted thoracic surgery (VATS) techniques, previ-
ous malignancy, and high-predicted surgical risk by European Society 
Objective Score .01. Less complete intraoperative lymph node excision 
was associated with cases performed by VATS and in octogenarians.
Conclusions: There is continued adherence to the guidelines, when 
considering cases in terms of anatomical resections, and marked 
improvement in complying with the gold standards for lymph node 
excision. The use of the audit tool has contributed to improved qual-
ity of surgical care in patients operated for lung cancer.
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Surgery remains the best available treatment for early non–small-cell lung cancer (NSCLC). The aim of surgery in 
those with NSCLC is not only complete resection of the pri-
mary tumor with clear margins, but also the achievement of 
accurate mediastinal staging.
As part of our commitment to self-evaluation and 
quality assurance, we elected to investigate some potential 
markers of surgical quality. On the basis of a review of the 
evidence, two major gold standards of intraoperative care for 
patients with early-stage NSCLC can be identified. First, on 
the basis of the only randomized controlled trial available, a 
nonanatomic resection (wedge excision) carries increased risk 
of local recurrence, hence anatomical resections should be 
the standard of care.1 Second, after a working group reviewed 
the evidence of the European Society of Thoracic Surgeons, it 
was recommended that a lymphadenectomy of three medias-
tinal nodal stations (one of them being subcarinal) should be 
part of all pulmonary resections for NSCLC.2
The aim of the audit was to measure improvement in 
surgical performance by reauditing anatomical resection and 
lymph node excision in patients undergoing lung cancer sur-
gery. The gold standards by which performance was rated were:
•  Anatomical resection should be the treatment of choice for 
NSCLC;
•  At least three N2 stations should be excised during surgery 
for NSCLC.
MATERIALS AND METHODS
Methods
Our strategy included performing an initial retrospec-
tive audit to ascertain current adherence to the gold standards. 
Once the initial audit was performed, an evaluation of the 
practice and a reaudit was performed prospectively. In addi-
tion, we investigated possible reasons for nonadherence to the 
gold standards in our patient population. The audit, includ-
ing collection and reporting of data, was approved and sup-
ported by the audit and clinical governance department of our 
hospital.
The initial audit included retrospective data of patients 
with primary lung cancer operated on by a single surgeon 
between July 2009 and October 2010. The outcomes were 
compared with the results of the prospective reaudit data, 
including that of patients from November 2010 to October 
2011. Clinical data and rates of anatomical resection and 
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lymph node excision were collected from the department’s 
surgical database along with individual review of operative 
notes and histopathology reports. Every patient was evaluated 
by a respiratory physician and discussed at a multidisciplinary 
meeting. Routine preparation for surgery included staging 
computer tomography scan (CT) and CT-positron emission 
tomography before surgery (endobronchial ultrasound and/
or mediastinoscopy was performed when indicated by size of 
the lymph nodes on CT scan or increased activity on positron 
emission tomography scan). physiological assessment 
with pulmonary function test, and clinical examination 
(measurement of transfer factor, regional distribution 
of perfusion, echocardiogram, and exercise testing were 
performed when considered necessary).3 These protocols of 
care, including indications for invasive staging, did not change 
during the two periods.
Our audit methodology is standard. First, we chose the 
topic to evaluate and then decided on the gold standards to 
compare it with. Data were initially collected and analyzed 
retrospectively, and deviations from the gold standards were 
noted along with identification of cases with worse adherence 
to standards. The results were presented and divulgated within 
the unit, and a reinforcement of the standards took place within 
the team (intervention). This was assumed as the change in 
practice for the purpose of re-evaluation, thus, completing the 
audit cycle. The reaudit was, therefore, a prospective one, aim-
ing for a similar size sample as the initial audit.
Patient Demographics
The results of the initial audit included data of 100 
patients (61 men and 39 women, median age of 71 years [range, 
37–90]). The reaudit included 102 consecutive patients (63 men 
and 39 women, median age 69 years [range, 34–85]). We used 
ESOS.01 as predictor of hospital mortality after lung resection.4,5 
Demographic data of the two groups are shown in Table 1.
Statistical Analysis
Data are expressed on median (range), unless stated. 
Analysis was performed using the χ2 test for qualitative, 
and Wilcoxon rank test for quantitative data, respectively. 
Variables that showed p values less than 0.1 on univariate 
analysis were entered on a binary logistic regression for mul-
tivariate analysis. p Values of less than 0.05 were considered 
significant, throughout.
RESULTS
Nonanatomical Resections
The procedures performed in both groups are shown 
in Figure 1. There was a reduction in the rates of anatomical 
segmentectomies and pneumonectomies, and an increase in 
the rate of lobectomies and the use of broncho-angioplastic 
techniques. This variation can only be explained by case load 
because the indications for the different types of surgery did 
not change in our team.
The histological tumor type in the initial audit group 
was adenocarcinoma in 47% of cases, squamous cell in 37%, 
undifferentiated large-cell carcinoma in 7%, and mixed ade-
nosquamous, neuroendocrine, and carcinoids in 3% each, 
respectively. This was similar to 44% adenocarcinoma, 37% 
squamous cell carcinoma, 2% large-cell undifferentiated, 
mixed type in 8%, neuroendocrine tumors 4%, and carcinoids 
5%, respectively, in the reaudit group.
There were no significant differences between the two 
groups in terms of failure to perform an anatomical resec-
tion. In the initial audit 12% of the cases underwent a wedge 
excision, and although the rate decreased to 6% in the reaudit 
group, this did not achieve statistical significance (p = 0.09)
Three factors were related to use of wedge excision in 
the entire study: use of video assisted thoracic surgery tech-
niques (31% versus 5% in open surgery; p < 0.001), previous 
history of other cancers (20% versus 4% when no previous 
history; p = 0.002), and high ESOS.01 score, that is, greater 
than 10% (17% versus 5% when ESOS <10; p = 0.008). All 
these factors remained associated with the use of nonanatomi-
cal resections on multivariate analysis (p < 0.05 in all cases).
Mediastinal Lymphadenectomy
We encountered a large proportion of patients having 
some intraoperative mediastinal lymph node excision (86% 
in audit and 88% in reaudit groups, respectively). However, 
when we compared our results with the gold standards (at least 
3 N
2
 stations were required), we fell short of these standards. 
We noted a significant increase in the extension of mediasti-
nal lymphadenectomy after the initial audit was performed. 
During the initial audit, at least one N
2
 station in 86%, at least 
two stations in 63%, and at least three stations, including sub-
carinal, in 40% of the cases, respectively, were excised. All 
these results improved in the reaudit group to 91%, 77%, and 
63%, respectively (p = 0.5, 0.06, and 0.003, Fig. 2).
TABLE 1.  Demographics of the Two Groupsa
Audit  
(July 2009–Oct 2010)
Reaudit  
(Nov 2010–Oct 2011) p
No. of patients 100 102
Men:women 61:39 59:43 0.8
Median age (yr) 71 (37–90) 69 (34–85) 0.4
Age > 80 yr 16% 11% 0.3
FEV1 80 (30–144)% 73 (18–144)% 0.04
PpoFEV1 62 (24–129)% 52 (16–106)% 0.2
PpoFEV1<40% 25% 22% 0.6
ESOS.01 5.5 (0.1–34.8) 5.3 (0.1–37.4) 0.5
ESOS.01 >10 30% 26% 0.6
VATS 11% 18% 0.2
Hypertension 45% 38% 0.8
Cardiac  
comorbidity
28% 25% 0.8
Pulmonary  
comorbidity
38% 40% 0.9
Diabetes 5% 17% 0.3
Previous cancer 25% 24% 0.8
Mortality 4% 2% 0.4
aExpressed as median (range) or percentage.
ESOS, European Society Objective Score; FEV1, forced expiratory volume in 1 
second; VATS, video assisted thoracic surgery.
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On univariate analysis, age more than 80 years (63% 
versus 46% when age is <80 years; p = 0.04), use of VATS 
(93% versus 41% in open surgery; p < 0.001), and high 
ESOS.01 score greater than 10% (58% versus 45% when 
ESOS <10; p = 0.09) were associated with less extensive 
mediastinal lymphadenectomy. On multivariate analysis, only 
age more than 80 years (p = 0.01) and use of VATS (p < 0.001) 
remained as predictors of less extensive intraoperative medi-
astinal staging.
DISCUSSION
We present the result of completing the audit cycle, to 
evaluate our surgical practice and to attempt to improve the care 
given to our patients. Even in a practice with a high motivation 
to provide best care to a surgical population, performing an 
audit will identify areas of improvement.6 In our case, the initial 
audit identified that the presumed excellent care provided 
to patients could be improved (only 12% of nonanatomical 
resections and 40% of cases had an adequate mediastinal 
exploration during surgery). These results motivated more 
careful attention to detail pre- and intraoperatively, and a more 
determined approach to improve surgical quality. The reaudit 
to complete the circle confirmed the improvement of the care 
given to our patients during surgery with a huge margin,which 
was greater than 50% in the rate of complete mediastinal 
staging (40%–63%). Our results emphasize the role of audit 
as a tool, not only to evaluate a practice, but also to improve 
outcomes when the audit cycle is completed.7 We assumed that 
the only change in practice was the data analysis of the initial 
audit together with the divulgation of the results to all members 
of the team, and the reinforcement of the gold standards. The 
results of the audit helped to identify the group of patients at a 
greater risk of nonadherence to these standards.
Our choice of gold standards followed the best available 
evidence (randomized controlled trial) and/or expert recom-
mendations. In particular, the work produced by the European 
Society of Thoracic Surgeons working group on intraopera-
tive mediastinal staging was very important in emphasizing 
quality for lung cancer surgery, and it has been used for qual-
ity assessment by different authors.8
Finally, we also wanted to ascertain the reasons why 
the gold standards were not provided to all patients even after 
FIGURE 1.  Procedures performed during the study. Although the rate of nonanatomical resections decreased from  
12% to 6%, this was not significant. (p = 0.09.)
FIGURE 2.  Mediastinal intraoperative staging. (p = 0.003 for at least 3 N2 stations.)
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completing the audit cycle. For this reason, we performed 
univariate and multivariate analyses to point out areas for 
future improvement. Our current rate of 6% to 12% usage of 
wedge resections for NSCLC is reasonably low and compares 
well with available databases, such as data from Society of 
Thoracic Surgeons, which reported 18% wedge resections,9 or 
a survey of the American College of Surgeons, which reported 
15.6% nonanatomical resections.10 It is not surprising that the 
use of wedge excisions were associated with history of cancer 
and use of VATS. The results reflect the practice of performing 
a VATS excision of a nodule in a patient with a history of dis-
tant cancer; after histological examination, if the results reveal 
a new cancer of pulmonary origin, patients might choose care-
ful follow-up rather than completion lobectomy.
We also identified high-predicted mortality risk (high 
ESOS score) as predictor for use of wedge excision, with a 
quarter of patients having an estimated mortality risk greater 
than 10% and undergoing wedge excision.
In terms of lymphadenectomy, our final results after 
reaudit are not too far off from those reported in the literature 
(Table 2).9,11–13 We were not surprised to find that the identi-
fied age related to incomplete mediastinal staging was more 
than 80 years because this group of patients are less likely 
to be given adjuvant chemotherapy, even in the presence 
of occult N
2
 disease.14 Another group of patients whom we 
identified as possible candidates for improvement were those 
undergoing VATS lobectomy, which was currently performed 
through the single-port technique.15 We believe that the results 
in this group of patients can be attributed to two factors: first, 
the learning curve in the use of VATS techniques that will 
undoubtedly affect the extent of lymphadenectomy. Second, 
some high-risk patients would not be considered fit to toler-
ate a lobectomy or a thoracotomy, so a VATS lobectomy or 
wedge might not have been followed by an extensive medias-
tinal exploration because the patients would have never been 
candidates for adjuvant chemotherapy in any way. We did not 
identify high-predicted operative risk as an independent pre-
dictor of incomplete intraoperative mediastinal staging.
We acknowledge the potential pitfalls of our study. It 
is not a result of a randomized trial, and it was partially per-
formed as a retrospective study (initial audit). It does compare 
cohorts of patients with some differences in the type of pro-
cedures performed. However, we are of the opinion that these 
differences exist because of random differences in case load 
because the surgical team and the indications for surgery did 
not change throughout the study. As the data were very con-
temporary, any possible differences in long-term outcomes 
such as survival cannot be assessed. In any case, the relatively 
small population size was not strong enough to show any sur-
vival differences. In addition, although the scientific value of 
the article might not apply to the entire surgical community, 
we believe that its essence (audit performance, change prac-
tice, and reaudit outcomes) will do so.
In summary, we have used the audit tool to identify 
deficiencies and improve quality of surgical care in our lung 
cancer population by adherence to gold standards of ana-
tomical resections and intraoperative mediastinal staging. 
For the future, we have identified the group of patients more 
likely to not comply with standards, so increased attention 
can target improvements in the care of these patients who 
are at risk. As we continue a self-assessment and evaluation 
of the quality of all processes of care in our unit, this topic 
will be reaudited in the future, using our latest results as gold 
standards.
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TABLE 2.  Some Results of Intraoperative Staging  during 
Treatment Non–Small-Cell Lung Cancer—11 as Part of 
ECOG9 Using STS Data and14 as Part of NCCN Data
Author Year Definition Results (%)
Keller11 2000 ≥2 N2 49.8
Doddoli12 2005 ≥2 N2 55
Boffa9 2008 Lymph node dissection 41
D’Amico14 2011 3 stations 58–66
ECOG, Eastern Cooperative Oncology Group; NCCN, National Comprehensive 
Cancer Network; STS, Society of Thoracic Surgeons.
